Astrazeneca (AZN) Stock Moves -0.45%: What You Should Know [Yahoo! Finance]
AstraZeneca PLC - American Depositary Shares (AZN)
Last astrazeneca plc - american depositary shares earnings: 2/5 04:00 pm
Check Earnings Report
US:NYSE Investor Relations:
astrazeneca.com/investor-relations.html
Company Research
Source: Yahoo! Finance
The stock outperformed the S&P 500, which registered a daily loss of 1.12%. Meanwhile, the Dow experienced a drop of 0.31%, and the technology-dominated Nasdaq saw a decrease of 2.04%. Prior to today's trading, shares of the pharmaceutical had lost 3.12% over the past month. This has lagged the Medical sector's loss of 2.99% and the S&P 500's loss of 2.91% in that time. The investment community will be closely monitoring the performance of Astrazeneca in its forthcoming earnings report. In that report, analysts expect Astrazeneca to post earnings of $1.10 per share. This would mark year-over-year growth of 6.8%. In the meantime, our current consensus estimate forecasts the revenue to be $13.6 billion, indicating a 7.3% grow
Read more
Impact Snapshot
Event Time:
AZN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
AZN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
AZN alerts
High impacting AstraZeneca PLC - American Depositary Shares news events
Weekly update
A roundup of the hottest topics
AZN
News
- Healthy Returns: AstraZeneca cholesterol pill shows promise as race with Merck heats up [CNBC]CNBC
- Former Pfizer CSO Mikael Dolsten on writing his next chapter, embracing AI and asking the ‘big questions' [Yahoo! Finance]Yahoo! Finance
- IgniteData to deploy EHR-to-EDC automation tool in Phase III trial at MSK [Yahoo! Finance]Yahoo! Finance
- ??AZD0780, a novel oral PCSK9 inhibitor, demonstrated significant LDL cholesterol (LDL-C) reduction in PURSUIT Phase IIb trialBusiness Wire
- IMFINZI® (durvalumab) approved in the US as first and only perioperative immunotherapy for patients with muscle-invasive bladder cancer [Yahoo! Finance]Yahoo! Finance
AZN
Sec Filings
- 4/1/25 - Form 6-K
- 3/31/25 - Form 6-K
- 3/31/25 - Form 6-K
- AZN's page on the SEC website